SCHEDULE 13D/A

ANI Pharmaceuticals Inc

Common Stock, $0.0001 par value per share · CUSIP: 00182C103

Event date: 2025-03-11

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Meridian Venture Partners II GP, L.P. ("GP")Reported CIK 0001580170

  Shares: 1,164,381.00 · Class: 5.4%

• Meridian Venture Partners II, L.P.Reported CIK 0001109507

  Shares: 1,164,381.00 · Class: 5.4%

• Meridian Venture Partners II, Co.Reported CIK 0001580169

  Shares: 1,164,381.00 · Class: 5.4%

• Robert E. Brown, Jr.Reported CIK 0001579672

  Shares: 1,184,570.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.